Karbasokroom
  • KarbasokroomKarbasokroom

Karbasokroom

Karbasokroom võib vähendada kapillaaride läbilaskvust, soodustada kahjustatud kapillaaride otsa ja hemostaasi kokkutõmbumist. Seda kasutatakse peamiselt verejooksu korral, mis on põhjustatud kapillaaride suurema läbilaskvuse tõttu, näiteks idiopaatiline purpur, võrkkesta verejooks, krooniline kopsuverejooks, seedetrakti verejooks, ninaverejooks Chemicalbook, hemoptysis , hematuuria, hemorroidiverejooks, emaka veritsus, ajuverejooks jne. See on vähem efektiivne massiivse verejooksu ja arteriaalse verejooksu korral. Hemostaatiline aine lilla klassi haiguse, päriliku kapillaaride laienemise ja kopsude, neerude, soolte, aju, emaka ennetamiseks ja muud verejooksud

Saada päring

Tootekirjeldus

Karbasokroom


Karbasokroom /Adrenosem CAS:69-81-8

Karbasokroom Chemical Properties
MF: C10H12N4O3
MW: 236,23
EINECS: 200-717-0
Sulamistemperatuur: 203 ° (laguneb)
Tihedus: 1,63 ± 0,1 g / cm3 (ennustatud)
Pka: 12,38 ± 0,40 (ennustatud)
Merck: 14 172

Karbasokroom /Adrenosem CAS:69-81-8 Spetsifikatsioon:

Üksus

Spetsifikatsioon

Välimus

Kollakaspunane kristall või kristalliline pulber

Identifitseerimine

Vastab nõuetele

Sulamispunkt

222 ° C

Neelduvus

1054 ~ 1130

Raskemetallid

â ‰ ¤30ppm

Raud

â ‰ ¤60 lk / min

Kloriid

â ‰ ¤0,041%

Arseen

â ‰ ¤2ppm

Kaotus kuivatamisel

â ‰ ¤1,0%

Süüte ümberkorraldamine

â ‰ ¤0,1%

Analüüs

â ‰ ¥ 98,0%


Karbasokroom /Adrenosem CAS:69-81-8 Introduction:
Karbasokroom is a hemostatic agent that promotes clotting, preventing blood loss from open wounds. It is an oxidation product of adrenaline which enhances the microcirculatory tone 4. In the future this may prevent excessive blood flow during surgical operations and the treatment of hemorrhoids, but research on effectiveness and severity of side effects remains inconclusive. It is not FDA-approved but is available as tablets or 
IM / SC süstid verejooksude ravis paljudes riikides.
Karbasokroom has been investigated for use in the treatment of non-surgical acute uncomplicated hemorrhoids in a mixture with Troxerutin, and this combination therapy demonstrated efficacy and safe tolerability either at a local or systemic level 1.

Karbasokroom /Adrenosem CAS:69-81-8 Function
1. Hemostatic. Karbasokroom is used for the expansion of hair type purple class, hereditary capillary expansion and prevention of lung, kidney, intestine, brain and uterine bleeding.
2. Karbasokroom can reduce the permeability of capillaries and promote the retraction of damaged capillaries to stop bleeding. Mainly used in capillary permeability increase due to bleeding, such as idiopathic purpura, retinal hemorrhage and chronic lung hemorrhage, gastrointestinal bleeding, epistaxis, haemoptysis, hematuria, hemorrhoids bleeding, uterine hemorrhage, cerebral hemorrhage, etc. The effect of hemorrhage and arterial hemorrhage is poor. Hemostatic medicine, used in the development of hair purple class, hereditary capillary expansion and prevention of lung, kidney, intestines, brain, uterus and other bleeding.

Karbasokroom /Adrenosem CAS:69-81-8 Application:
Karbasokroom can reduce the permeability of capillaries and promote the retraction of damaged capillaries and hemostasis. It is mainly used for bleeding caused by increased capillary permeability, such as idiopathic purpura, retinal hemorrhage, chronic pulmonary hemorrhage, gastrointestinal hemorrhage, nasal Chemicalbook epistaxis, hemoptysis, hematuria, hemorrhoid hemorrhage, uterine hemorrhage, cerebral hemorrhage, etc. It is less effective in treating massive bleeding and arterial bleeding. Hemostatic, used for persistent purple disease, hereditary capillary expansion and to prevent bleeding of lung, kidney, intestine, brain, uterus, etc



Kuumad sildid: Karbasokroom, tootjad, tarnijad, tehas, Hiina, valmistatud Hiinas, odav, allahindlus, madal hind

Seotud kategooria

Saada päring

Palun esitage oma päring allolevas vormis. Vastame teile 24 tunni jooksul.
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept